Gonadotropin-releasing hormone agonist to induce final oocyte maturation prevents the development of ovarian hyperstimulation syndrome in high-risk patients and leads to improved clinical outcomes compared with coasting

被引:42
作者
DiLuigi, Andrea J. [1 ]
Engmann, Lawrence [1 ]
Schmidt, David W. [1 ]
Maier, Donald B. [1 ]
Nulsen, John C. [1 ]
Benadiva, Claudio A. [1 ]
机构
[1] Univ Connecticut Hlth Ctr, Ctr Adv Reprod Serv, Div Reprod Endocrinol & Infertil, Farmington, CT 06030 USA
关键词
GnRH agonist; GnRH antagonist; OHSS; high responder; IN-VITRO FERTILIZATION; HUMAN CHORIONIC-GONADOTROPIN; GNRH ANTAGONIST GANIRELIX; EMBRYO-TRANSFER; FOLLICULAR MATURATION; INVITRO FERTILIZATION; SYNDROME OHSS; OVULATION; IVF; CYCLES;
D O I
10.1016/j.fertnstert.2009.10.034
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Ninety-four women undergoing IVF with peak E-2 level>4000 pg/mL received leuprolide acetate (LA) trigger (LA trigger group) or had gonadotropins withheld for one or more days (coasting group) followed by hCG trigger, unless cycle cancellation occurred. There were no cases of ovarian hyperstimulation syndrome in either group, and the LA trigger group had significantly more oocytes retrieved (26.9 +/- 9.5 vs. 17.7 +/- 9.3) P<0.001, more normally fertilized oocytes (15.0 +/- 7.8 vs. 10.3 +/- 6.3) P=0.01, and higher clinical and ongoing pregnancy rates than the coasting group (52.5% vs. 27.2%; 49.2% vs. 24.2%, P=0.02 for both comparisons, respectively). (Fertil Steril (R) 2010;94:1111-4. (C)2010 by American Society for Reproductive Medicine.)
引用
收藏
页码:1111 / 1114
页数:4
相关论文
共 52 条
[1]   A prospective randomized study comparing coasting with GnRH antagonist administration in patients at risk for severe OHSS [J].
Aboulghar, Mohamed A. ;
Mansour, Ragaa T. ;
Amin, Yahia M. ;
Al-Inany, Hesham G. ;
Aboulghar, Mona M. ;
Serour, Gamal I. .
REPRODUCTIVE BIOMEDICINE ONLINE, 2007, 15 (03) :271-279
[2]   Triggering ovulation with gonadotropin-releasing hormone agonists does not compromise embryo implantation rates [J].
Acevedo, Belen ;
Gomez-Palomares, Jose Luis ;
Ricciarelli, Elisabetta ;
Hernandez, Eleuterio R. .
FERTILITY AND STERILITY, 2006, 86 (06) :1682-1687
[3]   Value of measuring serum FSH in addition to serum estradiol in a coasting programme to prevent severe OHSS [J].
Al-Shawaf, T ;
Zosmer, A ;
Tozer, A ;
Gillott, C ;
Lower, AM ;
Grudzinskas, JG .
HUMAN REPRODUCTION, 2002, 17 (05) :1217-1221
[4]   Prevention of severe ovarian hyperstimulation syndrome in IVF with or without ICSI and embryo transfer: a modified 'coasting' strategy based on ultrasound for identification of high-risk patients [J].
Al-Shawaf, T ;
Zosmer, A ;
Hussain, S ;
Tozer, A ;
Panay, N ;
Wilson, C ;
Lower, AM ;
Grudzinskas, JG .
HUMAN REPRODUCTION, 2001, 16 (01) :24-30
[5]   Withholding gonadotropin administration is an effective alternative for the prevention of ovarian hyperstimulation syndrome [J].
Benadiva, CA ;
Davis, O ;
Kligman, I ;
Moomjy, M ;
Liu, HC ;
Rosenwaks, Z .
FERTILITY AND STERILITY, 1997, 67 (04) :724-727
[6]   Induction of the endogenous gonadotrophin surge for oocyte maturation with intra-nasal gonadotrophin-releasing hormone analogue (buserelin): effective minimal dose [J].
Buckett, WM ;
Bentick, B ;
Shaw, RW .
HUMAN REPRODUCTION, 1998, 13 (04) :811-814
[7]  
CASPER RF, 1979, SCIENCE, V205, P408, DOI 10.1126/science.377491
[8]   Comoarison of coastina and intravenous albumin in the prevention of ovarian hyperstimulation syndrome [J].
Chen, CD ;
Chao, KH ;
Yang, JH ;
Chen, SU ;
Ho, HN ;
Yang, YS .
FERTILITY AND STERILITY, 2003, 80 (01) :86-90
[9]  
CUMMINS J M, 1986, Journal of In Vitro Fertilization and Embryo Transfer, V3, P284, DOI 10.1007/BF01133388
[10]  
D'Angelo A, 2002, COCHRANE DB SYST REV, V3